fashion -WSS

fashion

author：leisure time 2025-10-01 21:40:33 - browse：9227

Closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. — A brain affected by Alzheimer's disease, at the Museum of Neuroanatomy at the University at Buffalo. David Duprey/AP

Investigators on Wednesday released the first detailed case report about a patient who died after receiving lecanemab, providing a new glimpse into safety concerns surrounding the closely watched experimental Alzheimer’s drug.

An unpublished version of the report was previously written about by Science in November, one of three deaths from the lecanemab trials revealed by Science and STAT. But the published version, in the New England Journal of Medicine, will allow doctors to evaluate the case as they consider whether and how to use a treatment that could be approved by the FDA as soon as this week.

This “will have greater impact on clinicians because it is peer-reviewed and published in the New England Journal,” said Lon Schneider, an Alzheimer’s expert at University of Southern California, who was not affiliated with the work.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

hotspot

leisure time

WSS

Does aspartame cause cancer? What new WHO guidance says

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Federal judge rules Oregon’s tough new gun law is constitutional

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Blood tests recalled over risk of missed heart attack diagnosis

knowledge

fashion

Wikipedia

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Mike Pence clashes with Tucker Carlson in Iowa

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Care demand spikes challenge UnitedHealth’s provider arm

Continuity nursing helped my family in our darkest PICU moments

Who gets to use the title 'doctor'?

Supreme Court strikes down use of affirmative action

It costs an awful lot of money to give away a kidney

Medical records are filled with copy

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

hotspot

'Null' research findings aren't empty of meaning. Let's publish them

Manchin, Huntsman team up to talk platform for 'unity' ticket that could run in 2024

Federal judge rules Oregon’s tough new gun law is constitutional

Late stage cancers on the rise after pandemic delayed screenings

Physicians aren't 'burning out.' They're suffering from moral injury

Physicians aren't 'burning out.' They're suffering from moral injury

Wikipedia

hotspot

leisure time

leisure time